Select a State

Global health R&D delivers for Tennessee

US government investment in global health R&D has delivered

$64.1 million
to Tennessee research institutions
850+ new jobs
for Tennessee

Neglected diseases in Tennessee

Chikungunya cases
58
Dengue cases
44
HIV diagnoses
7,485
Malaria cases
117
Tuberculosis cases
1,524
West Nile cases
138
Zika cases
62

Tennessee's top USG-funded global health R&D institutions

Vanderbilt University
$33.8 million
St. Jude Children's Research Hospital
$15.0 million
The University of Tennessee Health Science Center
$9.8 million
Meharry Medical College
$5.5 million

Tennessee industry in global health R&D

Immuno Technologies
Location(s):
Memphis
QuantuMDx
Location(s):
Chattanooga

Tennessee's top areas of global health R&D by USG funding

27.2%
HIV/AIDS
32.0%
Malaria
12.6%
Tuberculosis
3.7%
Diarrheal diseases
4.0%
Ebola/viral hemorrhagic fevers
5.0%
Rheumatic fever
9.1%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
6.4%
Other
Non-allocable

Global health R&D at work in Tennessee

Vanderbilt University researchers are working to stop mosquitoes from spreading disease. Their method uses Wolbachia, a bacterium found in more than 60 percent of the world’s insects. In mosquitoes, it hijacks their reproduction so that mostly only offspring carrying Wolbachia survive. Remarkably, it also prevents mosquitoes from carrying viruses like dengue and Zika. The scientists identified the two genes responsible for Wolbachia’s unique powers and found they can insert the genes directly into the insects’ genetic material, increasing the rate at which it spreads. These discoveries hold great promise for controlling the spread of insect-borne diseases.

Footnotes